Veracyte, Inc.
VCYT
$32.23
$0.090.28%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 118.07% | 151.17% | 168.25% | 76.96% | -636.03% |
| Total Depreciation and Amortization | -1.31% | -19.73% | -16.34% | -16.19% | -3.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -51.89% | -76.27% | 4.30% | 4.42% | 385.63% |
| Change in Net Operating Assets | -394.32% | 94.13% | -9.62% | -118.25% | 458.54% |
| Cash from Operations | 57.69% | 111.44% | 77.40% | -312.80% | 59.61% |
| Capital Expenditure | -65.84% | 19.99% | 24.50% | -114.90% | -33.39% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Investing | -2,068.24% | 19.99% | 24.50% | -88.05% | 90.55% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 84.20% | 387.83% | 0.31% | -25.09% | -1.99% |
| Repurchase of Common Stock | -190.51% | 10.87% | -46.24% | -68.29% | -113.45% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -799.22% | 9,253.64% | -102.77% | -151.28% | 593.55% |
| Foreign Exchange rate Adjustments | -235.02% | 182.49% | -771.43% | -316.00% | -59.43% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -346.68% | 237.60% | 99.62% | -129.86% | 188.23% |